10x Genomics organizacji Marża brutto
Jaka jest wartość Marża brutto organizacji 10x Genomics?
Wartość Marża brutto organizacji 10x Genomics, Inc. to 66.15%
Jaka jest definicja Marża brutto?
Marża brutto to różnica między przychodem a kosztem sprzedaży towarów podzielona przez przychód i wyrażona w procentach.
Gross margin is a type of profit margin, specifically a form of profit divided by net revenue. It is generally calculated as the selling price of an item, minus the cost of goods sold (production or acquisition costs, not including indirect fixed costs like rent, or administrative costs). The purpose of margins is to give a description of the gross profit.
Marża brutto firm w Health Care sektor na NASDAQ w porównaniu do 10x Genomics
Czym się zajmuję organizacja 10x Genomics?
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity on a cell-by-cell basis; single cell immune profiling for measuring the activity of immune cells and their targets; single cell ATAC for measuring epigenetics comprising the physical organization of DNA; and single cell multiome ATAC + gene expression for measuring the genetic activity and epigenetic programming in the same cells across tens of thousands of cells in a single experiment. The company also provides visium spatial gene expression solution for measuring spatial gene expression patterns across a single tissue sample or gene expression and protein co-detection when combined with immunofluorescence. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.
Firmy z marża brutto podobne do 10x Genomics
- Wartość Marża brutto organizacji Shilpa Medicare to 66.08%
- Wartość Marża brutto organizacji Vocera Communication Inc to 66.08%
- Wartość Marża brutto organizacji SPS Commerce to 66.09%
- Wartość Marża brutto organizacji First Property plc to 66.13%
- Wartość Marża brutto organizacji Solutions 30 SE to 66.14%
- Wartość Marża brutto organizacji Australian Ethical Investment Ltd to 66.14%
- Wartość Marża brutto organizacji 10x Genomics to 66.15%
- Wartość Marża brutto organizacji Western Areas to 66.16%
- Wartość Marża brutto organizacji RPG Life Sciences to 66.17%
- Wartość Marża brutto organizacji Chugai Pharmaceutical Co to 66.18%
- Wartość Marża brutto organizacji Presidio Property Trust to 66.19%
- Wartość Marża brutto organizacji Dragontail Systems to 66.21%
- Wartość Marża brutto organizacji Wishpond Technologies to 66.21%